FORM 6 - K
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Report of Foreign Private Issuer
Pursuant to Rule 13a - 16 or 15d - 16 of
the Securities Exchange Act of 1934
As of June 7, 2007
TENARIS, S.A.
(Translation of Registrant's name into English)
TENARIS, S.A.
46a, Avenue John F. Kennedy
L-1855 Luxembourg
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports
under cover Form 20-F or 40-F.
Form 20-F X Form 40-F
----- -----
Indicate by check mark whether the registrant by furnishing the
information contained in this Form is also thereby furnishing the information to
the Commission pursuant to Rule 12G3-2(b) under the Securities Exchange Act of
1934.
Yes No X
----- -----
If "Yes" is marked, indicate below the file number assigned to the registrant in
connection with Rule 12g3-2(b): 82- .
---
The attached material is being furnished to the Securities and Exchange
Commission pursuant to Rule 13a-16 and Form 6-K under the Securities Exchange
Act of 1934, as amended. This report contains Summary of the resolutions adopted
in the extraordinary general meeting of shareholders of Tenaris S.A. (the
"Company") held on June 6, 2007.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
Date: June 7, 2007
Tenaris, S.A.
By: /s/ Cecilia Bilesio
-----------------------
Cecilia Bilesio
Corporate Secretary
Summary of the resolutions adopted in the Extraordinary General Meeting of
shareholders of Tenaris S.A. (the "Company") held on June 6, 2007 at 46A, Avenue
John F. Kennedy L-1855, Luxembourg at 12:00.
1. The renewal of the validity period of the Company's authorized share
capital for a period starting on the date of the general meeting of shareholders
and ending on the fifth anniversary of the date of the publication in the
Memorial of the deed recording the minutes of such meeting and of the
authorisation to the Board to issue shares from time to time within the limits
of such authorised share capital against contribution in cash, in kind or by way
of incorporation of reserves, at an amount that may not be less than the par
value and may include such issue premium as the Board shall decide, while
reserving to existing shareholders the preferential right to subscribe for such
newly issued shares, except:
a) in circumstances in which the shares are issued for a consideration
other than cash;
b) with respect to shares issued as compensation to directors, officers,
agents, or employees of the Company, its subsidiaries or affiliates; and
c) with respect to shares issued to satisfy conversion or option rights
created to provide compensation to directors, officers, agents or employees of
the Company, its subsidiaries or affiliates. Any shares to be issued for the
purposes set forth in (b) and (c) may not exceed 1.5% of the Company's issued
share capital.
2. The waiver of any preferential subscription rights of existing
shareholders provided for by law and the authorisation to the Board to suppress
any preferential subscription rights of existing shareholders, each time with
respect to issuances of shares under (a), (b) and (c) above, and the
acknowledgement and approval of the report of the Board on the authorised share
capital and the proposed waiver and authorisation to the Board with respect to
such issuances.
The meeting resolved to renew the validity period of the Company's authorized
share capital for a period starting on the date of the general meeting of
shareholders and ending on the fifth anniversary of the date of the publication
in the Memorial of the deed recording the minutes of such meeting.
The meeting resolved to renew the authorization to the Board to issue shares
from time to time within the limits of such authorized share capital against
contribution in cash, in kind or by way of incorporation of reserves, at an
amount that may not be less than the par value and may include such issue
premium as the Board shall decide, while reserving to existing shareholders the
preferential right to subscribe for such newly issued shares, except:
a) in circumstances in which the shares are issued for a consideration
other than cash;
b) with respect to shares issued as compensation to directors, officers,
agents, or employees of the Com-pany, its subsidiaries or affiliates; and
c) with respect to shares issued to satisfy conversion or option rights
created to provide compensation to di-rectors, officers, agents or employees of
the Company, its subsidiaries or affiliates.
The meeting resolved that any shares to be issued for the purposes set forth in
(b) and (c) may not exceed 1.5% of the Company's issued share capital.
The meeting resolved to waive any preemptive subscription rights of existing
shareholders provided for by law and to authorize the Board to suppress any
preemptive subscription rights of existing shareholders, each time with respect
to issuance of shares under items (a), (b) and (c) of the above agenda.
The meeting acknowledged and approved the report by the Board of Directors on
the authorized share capital and the waiver of preemptive subscription rights
pursuant to article 32-3(5) of Luxemburg Company Law